A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors

IntroductionAnxiety disorders are among the most common mental illnesses in the US. An estimated 31.1% of U.S. adults experience any anxiety disorder at some time in their lives. Understanding some of the molecular underpinnings of anxiety could lead to improved treatments over current strategies fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristin R. Anderson, Wenpeng Cao, Hui Sun Lee, Mark A. Crenshaw, Talulla B. Palumbo, Ethan Fisher-Perez, Amanda DeGraaf, Peter Rogu, Maria A. Beatty, Gabrielle M. Gracias, Avani V. Pisapati, Katie Hoffman, Krystle J. McLaughlin, Almut Hupbach, Wonpil Im, X. Frank Zhang, Julie M. Miwa
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnbeh.2024.1347543/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850244062164025344
author Kristin R. Anderson
Wenpeng Cao
Hui Sun Lee
Mark A. Crenshaw
Talulla B. Palumbo
Ethan Fisher-Perez
Amanda DeGraaf
Peter Rogu
Maria A. Beatty
Gabrielle M. Gracias
Gabrielle M. Gracias
Avani V. Pisapati
Katie Hoffman
Krystle J. McLaughlin
Almut Hupbach
Wonpil Im
Wonpil Im
X. Frank Zhang
Julie M. Miwa
author_facet Kristin R. Anderson
Wenpeng Cao
Hui Sun Lee
Mark A. Crenshaw
Talulla B. Palumbo
Ethan Fisher-Perez
Amanda DeGraaf
Peter Rogu
Maria A. Beatty
Gabrielle M. Gracias
Gabrielle M. Gracias
Avani V. Pisapati
Katie Hoffman
Krystle J. McLaughlin
Almut Hupbach
Wonpil Im
Wonpil Im
X. Frank Zhang
Julie M. Miwa
author_sort Kristin R. Anderson
collection DOAJ
description IntroductionAnxiety disorders are among the most common mental illnesses in the US. An estimated 31.1% of U.S. adults experience any anxiety disorder at some time in their lives. Understanding some of the molecular underpinnings of anxiety could lead to improved treatments over current strategies focusing on symptom relief rather than root causes. One significant neurotransmitter system exerting control over anxiety is the nicotinic receptor subdivision of the cholinergic system. The murine Lynx2 gene, encoding a protein modulator of nicotinic acetylcholine receptors, is expressed in anxiety-related neural circuitry in rodents and has been functionally associated with anxiety-like behavior.MethodsWe examined variations in the human LYNX2 (LYPD1) gene and their potential effects on anxiety levels in a cohort of 624 participants. Participants completed validated anxiety questionnaires (e.g., STICSA and STAI), which assessed both their current anxiety and their general tendency to experience anxiety. Possible functional alterations due to one such mutation was assessed through atomic force microscopy (AFM) and computational modeling.ResultsWe identified a previously unreported single nucleotide polymorphism (SNP) in the mature protein-coding region of LYNX2 that was associated with significantly higher than normal anxiety scores. These elevated scores resembled those seen in patients clinically diagnosed with generalized anxiety disorder and panic disorder, although this genetically defined subpopulation did not typically report such diagnoses. Through computational modeling of the homopentameric α7 nicotinic receptor subtype and in vitro atomic force microscopy (AFM), we discovered that a specific LYNX2 SNP is linked to a reduced binding affinity between the LYNX2 protein and nAChRs, offering a potential functional explanation for the role that this mutation may play in anxiety.DiscussionA polymorphism in LYNX2, which codes for an inhibitory modulator of nicotinic acetylcholine receptors, has the potential to lead to sensitized nicotinic receptor activity in anxiety-related circuits. The LYNX2 protein has been shown to bind to multiple nicotinic acetylcholine receptor subtypes, including α4β2, α7, and α3β4 subtypes, each of which have been shown to be involved in affective behaviors. This work suggests that a subpopulation of individuals harboring a deleterious mutation in LYNX2 may predispose them to anxiety through abnormal nicotinic receptor control. In the future, this work may lead to the development of a biomarker for anxiety or a diagnostic tool for the early detection of individuals with susceptibility to anxiety.
format Article
id doaj-art-9518f5d64f6644dfa69bfe01bd7690cd
institution OA Journals
issn 1662-5153
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Behavioral Neuroscience
spelling doaj-art-9518f5d64f6644dfa69bfe01bd7690cd2025-08-20T01:59:51ZengFrontiers Media S.A.Frontiers in Behavioral Neuroscience1662-51532024-12-011810.3389/fnbeh.2024.13475431347543A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptorsKristin R. Anderson0Wenpeng Cao1Hui Sun Lee2Mark A. Crenshaw3Talulla B. Palumbo4Ethan Fisher-Perez5Amanda DeGraaf6Peter Rogu7Maria A. Beatty8Gabrielle M. Gracias9Gabrielle M. Gracias10Avani V. Pisapati11Katie Hoffman12Krystle J. McLaughlin13Almut Hupbach14Wonpil Im15Wonpil Im16X. Frank Zhang17Julie M. Miwa18Department of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesBS, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United StatesDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Psychology, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United StatesDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United StatesDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, United StatesIntroductionAnxiety disorders are among the most common mental illnesses in the US. An estimated 31.1% of U.S. adults experience any anxiety disorder at some time in their lives. Understanding some of the molecular underpinnings of anxiety could lead to improved treatments over current strategies focusing on symptom relief rather than root causes. One significant neurotransmitter system exerting control over anxiety is the nicotinic receptor subdivision of the cholinergic system. The murine Lynx2 gene, encoding a protein modulator of nicotinic acetylcholine receptors, is expressed in anxiety-related neural circuitry in rodents and has been functionally associated with anxiety-like behavior.MethodsWe examined variations in the human LYNX2 (LYPD1) gene and their potential effects on anxiety levels in a cohort of 624 participants. Participants completed validated anxiety questionnaires (e.g., STICSA and STAI), which assessed both their current anxiety and their general tendency to experience anxiety. Possible functional alterations due to one such mutation was assessed through atomic force microscopy (AFM) and computational modeling.ResultsWe identified a previously unreported single nucleotide polymorphism (SNP) in the mature protein-coding region of LYNX2 that was associated with significantly higher than normal anxiety scores. These elevated scores resembled those seen in patients clinically diagnosed with generalized anxiety disorder and panic disorder, although this genetically defined subpopulation did not typically report such diagnoses. Through computational modeling of the homopentameric α7 nicotinic receptor subtype and in vitro atomic force microscopy (AFM), we discovered that a specific LYNX2 SNP is linked to a reduced binding affinity between the LYNX2 protein and nAChRs, offering a potential functional explanation for the role that this mutation may play in anxiety.DiscussionA polymorphism in LYNX2, which codes for an inhibitory modulator of nicotinic acetylcholine receptors, has the potential to lead to sensitized nicotinic receptor activity in anxiety-related circuits. The LYNX2 protein has been shown to bind to multiple nicotinic acetylcholine receptor subtypes, including α4β2, α7, and α3β4 subtypes, each of which have been shown to be involved in affective behaviors. This work suggests that a subpopulation of individuals harboring a deleterious mutation in LYNX2 may predispose them to anxiety through abnormal nicotinic receptor control. In the future, this work may lead to the development of a biomarker for anxiety or a diagnostic tool for the early detection of individuals with susceptibility to anxiety.https://www.frontiersin.org/articles/10.3389/fnbeh.2024.1347543/fullLynx2LYPD1nicotinic acetylcholine receptorsanxiety disordershuman psychologyhuman DNA analysis
spellingShingle Kristin R. Anderson
Wenpeng Cao
Hui Sun Lee
Mark A. Crenshaw
Talulla B. Palumbo
Ethan Fisher-Perez
Amanda DeGraaf
Peter Rogu
Maria A. Beatty
Gabrielle M. Gracias
Gabrielle M. Gracias
Avani V. Pisapati
Katie Hoffman
Krystle J. McLaughlin
Almut Hupbach
Wonpil Im
Wonpil Im
X. Frank Zhang
Julie M. Miwa
A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors
Frontiers in Behavioral Neuroscience
Lynx2
LYPD1
nicotinic acetylcholine receptors
anxiety disorders
human psychology
human DNA analysis
title A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors
title_full A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors
title_fullStr A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors
title_full_unstemmed A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors
title_short A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors
title_sort novel anxiety associated snp identified in lynx2 lypd1 is associated with decreased protein binding to nicotinic acetylcholine receptors
topic Lynx2
LYPD1
nicotinic acetylcholine receptors
anxiety disorders
human psychology
human DNA analysis
url https://www.frontiersin.org/articles/10.3389/fnbeh.2024.1347543/full
work_keys_str_mv AT kristinranderson anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT wenpengcao anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT huisunlee anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT markacrenshaw anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT talullabpalumbo anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT ethanfisherperez anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT amandadegraaf anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT peterrogu anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT mariaabeatty anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT gabriellemgracias anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT gabriellemgracias anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT avanivpisapati anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT katiehoffman anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT krystlejmclaughlin anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT almuthupbach anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT wonpilim anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT wonpilim anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT xfrankzhang anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT juliemmiwa anovelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT kristinranderson novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT wenpengcao novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT huisunlee novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT markacrenshaw novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT talullabpalumbo novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT ethanfisherperez novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT amandadegraaf novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT peterrogu novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT mariaabeatty novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT gabriellemgracias novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT gabriellemgracias novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT avanivpisapati novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT katiehoffman novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT krystlejmclaughlin novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT almuthupbach novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT wonpilim novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT wonpilim novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT xfrankzhang novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors
AT juliemmiwa novelanxietyassociatedsnpidentifiedinlynx2lypd1isassociatedwithdecreasedproteinbindingtonicotinicacetylcholinereceptors